Propeller Health and Novartis received the green light from European regulators to package their products together. The move is one step of many to make digital therapeutics easier to prescribe.
The company said the FDA gave it a 510(k) clearance for the use of Propeller, which combines sensors attached to inhalers with an app, with AstraZeneca's Symbicort, for patients with asthma and COPD.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Healthcare startups saw smaller amounts of investment after a record-breaking 2018, according to a report from Silicon Valley Bank. Despite the dip in funding, 2019 saw more deals overall, led by increased investment into healthcare technology companies.
Digital health companies faced bad news going into 2020, from job cuts to dissolving pharma partnerships. But these struggles are part of an industry that is finding its identity in a crowded healthcare market.
David Van Sickle's eyes shine as he outlines the array of opportunities that have opened up ever since medical device maker ResMed acquired the Wisconsin startup in January 2019 for $225 million.
Find Care, which was launched one year ago, was initially started to help patients find and identify location specific healthcare services through the Walgreens app and website.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The research, which was published in the Journal of Telemedicine and Telecare, involved 39 patients who have COPD and had at least one hospitalization or emergency room visit during the year prior to enrollment.
Faster cash burn rates, lack of growth in startup exits and sky-high valuations are leaving some industry observers nervous that a major market correction is on the way.
Using My Pharmacy, Propeller Health users can refill prescriptions, find nearby Walgreens locations, communicate with pharmacists and check the balance of their Walgreens reward accounts.
Digital therapeutics company Propeller will continue to operate as a standalone business within ResMed's Respiratory Care portfolio.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
In a phone interview, Propeller Health CEO David Van Sickle and CTO Greg Tracy discussed how their digital therapeutics company has evolved since its founding in 2010.
Anthem Medicare Advantage members in Ohio with chronic obstructive pulmonary disease will be able to use Propeller's mobile app and its sensors that attach to inhalers.
The goal is to expand its connected device capabilities beyond asthma and COPD inhalers to include other diseases and drug delivery devices.
Express Scripts members who used Propeller's inhaler tracking tools had a significant improvement in adherence to their asthma controller medication, according to the pharmacy benefit manager.
Of the five major respiratory inhaler companies in the U.S., Propeller Health has now signed three. The latest addition, Novartis, gives Propeller an edge as it works to claim market share in the 'smart inhaler' sector projected to be worth $854 million per year by 2025.